Multiple Myeloma

April 3rd 2025

The study highlights the importance of including patient self-assessment—and not just clinician assessment—when planning treatment in multiple myeloma.

March 25th 2025

Ajai Chari, MD, stresses the importance of making bispecific therapies more accessible at the community level to improve outcomes in multiple myeloma.

March 21st 2025

Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.

March 20th 2025

Patients who did not complete a distress screener were also less likely to receive autologous stem cell transplants.